Reactive oxygen species induce a procoagulant state in endothelial cells by inhibiting tissue factor pathway inhibitor

[1]  Juhyun Song,et al.  Glutathione Protects Brain Endothelial Cells from Hydrogen Peroxide-Induced Oxidative Stress by Increasing Nrf2 Expression , 2014, Experimental neurobiology.

[2]  G. Dorn,et al.  Endothelial G Protein–Coupled Receptor Kinase 2 Regulates Vascular Homeostasis Through the Control of Free Radical Oxygen Species , 2013, Arteriosclerosis, thrombosis, and vascular biology.

[3]  P. Sandset,et al.  TFPIα and TFPIβ are expressed at the surface of breast cancer cells and inhibit TF-FVIIa activity , 2013, Journal of Hematology & Oncology.

[4]  G. Cimmino,et al.  The complex puzzle underlying the pathophysiology of acute coronary syndromes: from molecular basis to clinical manifestations , 2012, Expert review of cardiovascular therapy.

[5]  G. Broze,et al.  Tissue factor pathway inhibitor: structure-function. , 2012, Frontiers in bioscience.

[6]  F. Loffredo,et al.  Platelets release matrix metalloproteinase-2 in the coronary circulation of patients with acute coronary syndromes: possible role in sustained platelet activation. , 2011, European heart journal.

[7]  K. Hardy,et al.  Further Insight Into the Heparin-Releasable and Glycosylphosphatidylinositol-Lipid— Anchored Forms of Tissue Factor Pathway Inhibitor , 2008, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

[8]  R. Schnabel,et al.  Prognostic value of plasma tissue factor and tissue factor pathway inhibitor for cardiovascular death in patients with coronary artery disease: the AtheroGene study , 2007, Journal of thrombosis and haemostasis : JTH.

[9]  J. Zweier,et al.  The role of oxidants and free radicals in reperfusion injury. , 2006, Cardiovascular research.

[10]  V. Fuster,et al.  Tissue Factor Coagulation Pathway: A New Therapeutic Target in Atherothrombosis , 2004, Journal of cardiovascular pharmacology.

[11]  I. Kubo,et al.  Characterization of xanthine oxidase inhibition by anacardic acids. , 2004, Biochimica et biophysica acta.

[12]  M. Chiariello,et al.  Involvement of Tissue Factor Pathway Inhibitor in the Coronary Circulation of Patients With Acute Coronary Syndromes , 2003, Circulation.

[13]  F. Rosendaal,et al.  Low levels of tissue factor pathway inhibitor (TFPI) increase the risk of venous thrombosis. , 2003, Blood.

[14]  G. Cimmino,et al.  Targeting Tissue Factor as an Antithrombotic Strategy , 2003, Seminars in vascular medicine.

[15]  G. Cimmino,et al.  Role of tissue factor pathway inhibitor in the regulation of tissue factor-dependent blood coagulation. , 2006, Cardiovascular drug reviews.

[16]  M. Chiariello,et al.  Endogenous tissue factor pathway inhibitor modulates thrombus formation in an in vivo model of rabbit carotid artery stenosis and endothelial injury. , 2000, Circulation.

[17]  M. Condorelli,et al.  Antithrombotic effects of recombinant human, active site-blocked factor VIIa in a rabbit model of recurrent arterial thrombosis. , 1998, Circulation research.

[18]  M. Chiariello,et al.  A short burst of oxygen radicals at reflow induces sustained release of oxidized glutathione from postischemic hearts. , 1998, Free radical biology & medicine.

[19]  V. Ollivier,et al.  Effect of advanced glycation end product-modified albumin on tissue factor expression by monocytes. Role of oxidant stress and protein tyrosine kinase activation. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[20]  M. Chiariello,et al.  Oxygen radicals can induce preconditioning in rabbit hearts. , 1997, Circulation research.

[21]  E. Bramucci,et al.  Tissue-factor antigen and activity in human coronary atherosclerotic plaques , 1997, The Lancet.

[22]  V. Fuster,et al.  Tissue factor modulates the thrombogenicity of human atherosclerotic plaques. , 1997, Circulation.

[23]  C. Doutremépuich,et al.  Aspirin fails to prevent experimental arterial thrombosis induced by oxygen free radicals. , 1996, Thrombosis research.

[24]  H. Swanton,et al.  Myocardial reperfusion injury: experimental evidence and clinical relevance. , 1996, European heart journal.

[25]  M. Chiariello,et al.  Monoclonal antibody against tissue factor shortens tissue plasminogen activator lysis time and prevents reocclusion in a rabbit model of carotid artery thrombosis. , 1996, Circulation.

[26]  M. Condorelli,et al.  Effects of tissue factor induced by oxygen free radicals on coronary flow during reperfusion , 1996, Nature Medicine.

[27]  K. Kario,et al.  Decreased Plasma Tissue Factor Pathway Inhibitor Activity in Ischemic Stroke Patients , 1995, Thrombosis and Haemostasis.

[28]  V. Fuster,et al.  Evolving concepts in the pathogenesis and treatment of arterial thrombosis. , 1995, The Mount Sinai journal of medicine, New York.

[29]  P. Lesnik,et al.  Tissue factor pathway inhibitor activity associated with LDL is inactivated by cell- and copper-mediated oxidation. , 1995, Arteriosclerosis, thrombosis, and vascular biology.

[30]  G. Broze.  Tissue factor pathway inhibitor and the current concept of blood coagulation , 1995, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[31]  M. Chiariello,et al.  The role of oxygen free radicals in preconditioning. , 1995, Journal of molecular and cellular cardiology.

[32]  K. Channon,et al.  Differential Expression of Tissue Factor Protein in Directional Atherectomy Specimens From Patients With Stable and Unstable Coronary Syndromes , 1995 .

[33]  S. Westaby,et al.  Deferoxamine cardioplegia reduces superoxide radical production in human myocardium. , 1995, The Annals of thoracic surgery.

[34]  O. Alfieri,et al.  Myocardial damage during ischaemia and reperfusion. , 1993, European heart journal.